The nanoparticles presented high uptake by tumor cells, and curcumin (cleaved product of PCDA) downregulated the expression of P-gp, allowing an increase in paclitaxel accumulation within the target cancer cells, thereby enhancing the therapeutic efficacy against the MDR cells [48]. This evidence concerns the gene PGP and cancer.